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Background: Acupuncture is an effective yet complex therapy, integrating syndrome differentiation, selection of
appropriate acupoints and skillful needling techniques. Clinicians carefully tailor acupuncture treatment to each
patient. However, most clinical trials of acupuncture have been based on a standardized formula of points for every
patient without properly accounting for individualdifferences and, as a result, have not been reflective of the true
efficacy of clinical practice. To determine the efficacy of meridian-based syndrome differentiation and Sa-am
acupuncture, we have designed a simple pragmatic trial providing individualized treatments while working within a
general framework.
Methods/Design: The study is designed to be a parallel, patient- and assessor-blind, randomized controlled trial
(RCT). A total of250 patients with knee osteoarthritis (OA) will be recruited from two independent hospitals,
Semyung University Oriental Medicine Hospital in Chung-ju and Dongguk University Oriental Hospital in Ilsan,
South Korea. Patients will be randomly allocated into four treatment groups: 1. individualized, meridian-based
syndrome differentiation and Sa-am acupuncture treatment;2. standard acupuncture treatment;3. sham acupuncture
treatment; and 4. no acupuncture treatment. Patients in groups 1 to 3 will be treated by certified oriental medicine
doctors twice a week for 6 weeks. The primary outcome measure will be the self-reported total Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC) score change. The trial will also include secondary
outcome measures.
Discussion: This trial is designed to determine the efficacy of individualized acupuncture treatment in patients with
knee OA by comparing the differences between individualized, standard, sham and no acupuncture treatments.
The results of this trial may validate the efficacy of individualized acupuncture therapy, encouraging its widespread
use.
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Most clinical trials are designed to evaluate the efficacy
and safety of medical treatment [1]. Recently, there has
been increased interest in using acupuncture methods
and other alternative medicines for treating diseases [2],
especially those without effective conventional treatment
options, such as osteoarthritis(OA) [3]. OA is one of the
top ten disabilities affecting people in developed coun-
tries and significantly impacts the lives of many people
[4]. At present, however, no medications are available to
effectivelytreat OA. Since many patients are turning to
alternative therapies [5-7], it has become necessary to
determine their efficacy. For example, many clinical
trials have been performed to evaluate the efficacy of
acupuncture [8]. However, the results from these
studieshave been criticized owing to a lack of definitive
evidence regarding the efficacy of acupuncture; some
studies suggest that acupuncture has clear benefits,
whereas others are less conclusive [8].Many practicing
oriental medicine doctors believe that this lack of defini-
tive evidence is due to the absence of individualized
syndrome differentiation from the trial design, a funda-
mental aspect of traditional Chinese medicine [9].
Many clinical trials on acupuncture have been explana-
tory in nature, emphasizing the standardization of treat-
ments, rather than taking a pragmatic approach and
compiling clinically relevant data [10]. Clinical research
can be divided into two main categories, explanatory and
pragmatic. Explanatory trials focus on evaluating the effi-
cacy of a treatment in ideal, standardized environments,
whereas pragmatic trials seek to determine the efficacy in
clinically applicable settings [11,12]. Acupuncture therapy
involves various elements unique to individual patients.
For example, it must consider the signs and symptoms of
each patient in differential symptom diagnosis, select the
proper acupoints for a particular illness and utilize a re-
fined needling technique [13]. In addition, to enhance the
efficacy of treatment, the acupoints selected must be de-
termined based on an understanding of each patient's in-
dividual characteristics. Hence, explanatory trials based on
a single set of standardized acupoints are not appropriate
for testing the efficacy of acupuncture [10].
Although pragmatic trials more closely mimic clinical
settings, they also have inherent flaws. For example-
treatments often include minute variations, depending
on each clinician's diagnostic methods and needling
techniques, making the trials difficult to replicate
[14-16]. Thus, it is necessary to enhance the reproduci-
bility of pragmatic trials testing individualized acupunc-
ture therapy, so that other practitioners may be better
able to replicate the general techniques, while still mim-
icking routine clinical practice [12].
In this study, we propose to treat patients diagnosed
with knee OA with anindividualized, meridian-based[17]syndrome differentiation acupuncture method. For
each patient, we will select the most appropriate of the
many methods available, including the Eight Principles,
the Zang-fu organ system, the Qi-Blood-Yi method and
the Triple Burner [18].Meridian-based syndrome differ-
entiation was chosen because it allows the selection of
specific acupoints connected to the area of pain [19-21]
and considers the particular characteristics of each
patient, while still being a generalized, reproducible
method. Furthermore, a recent survey of oriental medi-
cine practitioners in Korea reported that meridian-based
syndrome differentiation, in conjunction with Sa-am
acupuncture, is the most commonly used form of acu-
puncture treatment in Korean clinical practice [21].
This trial is therefore designed to assess the efficacy of
meridian-based syndrome differentiation acupuncture
therapy. Patients will be randomly allocated into four
treatment groups: 1. individualized, meridian-based syn-
drome differentiation and Sa-am acupuncture treatment;2.
standard acupuncture treatment;3. sham acupuncture
treatment; and 4. no acupuncture treatment.
Methods/Design
Study design
This prospective parallel, single-blinded (assessor and
patient), randomized controlled trial (RCT) is designed
to assess the efficacy and safety of individualized acu-
puncture therapy in patients with knee OA. It will be
conducted at two clinical research centers in South
Korea, Semyung University Oriental Medicine Hospital
in Chung-ju and Dongguk University Oriental Hospital
in Ilsan, with patients divided into four parallel groups.
The research protocol has been approved by the institu-
tional review board (IRB) at each center, and each pa-
tient will be asked to provide informed consent.
Recruitment
Participants will be recruited through advertisements in
local newspapers and bulletin boards in each trial center,
with a target sample size of 250 patients. All patients will
be screened initially by telephone with regard to selec-
tion criteria. If appropriate, their eligibility will be deter-
mined by both an orthopedist and a radiologist through
physical and radiological examinations.
Participants
Patients will be selected from outpatients aged 40 years
to 80 years with painful knee OA, as defined by the
American College of Rheumatology (ACR) [22]. Patients
with pain in one or both knees during the previous
3 months or longer and rated >40 mm on a visual analog
scale (VAS; 0 to 100 mm) will be selected for the trial.
Patients will be excluded from the study if they have: 1.
trauma or surgery on the knee(s) within 6 months prior
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history of prolotherapy, with injections of hyaluronic
acid or cortisone within the previous 3 months; 3.
physical or laboratory findings indicating infection, the
presence of an autoimmune disease or inflammatory
arthritis; 4. serious organic disease (for example arrhyth-
mia, angina pectoris, stroke, asthma) with resultant se-
vere dysfunction; 5.more severe pain in regions other
than the knee joint; or 6.if they are pregnant. In addition,
to ensure that the results from this study are only due to
the treatments from this study, all participants will be
required to not have received acupuncture therapy for
2 weeks prior to entering this trial.
Randomization and blinding
Patients will be randomized by an independent statisti-
cian using a computerized, random-number generator
through the block-randomization method of SAS version
9.1(SAS Institute Inc, Cary, NC, USA) for sequence
generation. Separate randomization files will be created
for each of the two sites. Allocations will be concealed
using sealed, opaque envelopes. After the assessor has
screened the patient for inclusion and the patient has
signed the informed consent form, the next envelope in
the sequence will be provided, immediately prior to
treatment, to the certified oriental medicine doctor who
will perform acupuncture. By this method, a total of 250
participants will be randomly assigned to the four
groups. Although all patients and their screening asses-
sors will be blinded to treatment, the certified oriental
medicine doctor applying acupuncture will not.
Treatment
Patients will be randomly allocated into four treatment
groups: 1. individualized, meridian-based syndrome
differentiation and Sa-am acupuncture treatment;2.
standard acupuncture treatment;3 sham acupuncture
treatment; and 4. no acupuncture treatment. Patients in
groups 1 to 3 will be treated twice weekly for 6 weeks.
The trial length was based on a survey of certified orien-
tal medicine doctors, in which 50.6% of respondents in-
dicated that treatment for over 5 weeks is necessary to
treat chronic knee pain, such as that caused by OA.
For patients with bilateral OA, the side with more pain
at baseline, as assessed by a VAS, will be treated and
evaluated throughout the study.
General acupuncture preparation and needling technique
To ensure that the study is single-blinded and that pa-
tients are not aware of the differences between treat-
ments, we propose using a Park sham needle guide-tube
[23,24] for all three acupuncture treatment groups. This
will ensure that the patient will not observe any out-
wardly discernible differences among individualized,standard and sham acupuncture, although the penetra-
tion of the needles will differ among these three groups.
Prior to needle insertion, the area of the skin will be
sterilized. Acupuncture will be performed using sterile
stainless steel disposable acupuncture needles (DongBang
Acupuncture Inc, Korea).The depth of insertion at each
point was predetermined to be within the normal range of
8 mm to 30 mm, depending on the location of the point.
Following needle insertion, the acupuncture point will be
stimulated using bidirectional rotations of the needle
sleeve, to achieve the sensation known as Deqi.
In patients randomized tothe individualized and stand-
ard acupuncture groups, an electroacupuncture device
(STN-111,StraTek Co, Korea) will be used to provide
electrical stimulation to the proximal acupoints, with the
clinician adjusting the intensity so that the patientfeels
an uncomfortable but not painful sensation. The needles
will be kept in place for 20 minutes.
Due to ethical considerations, patients who have previ-
ously taken analgesics and non-steroidalanti-inflamma-
tory drugs (NSAIDs) will be allowed to continue to take
these medications during the study period. However, we
will request that patients avoid physical therapy as much
as possible to ensure that our results reflect the role of
acupuncture therapy, not other forms of treatment. Pa-
tients will be questioned about having received medica-
tion at each visit and this information will be recorded
for analysis of the data.
Individualized acupuncture
The diagnostic and treatment techniques to be used in
the individualized acupuncture group were determined
through interviews conducted with 234 Korean oriental
medicine practitioners between 23November 2009 and 9
January 2010 (Kim et al., unpublished data). This survey
found that the most frequently used syndrome differen-
tiation and acupuncture method for knee pain were
syndrome differentiation based on meridian theory and
Sa-am acupuncture. Many oriental medicine doctors in
Korea performed acupuncture on both the proximal and
distal acupoints at the same time. Based on these find-
ings, the individualized treatment method that will be
used in this study is meridian-based syndrome differenti-
ation and Sa-am acupuncture. Two types of acupoints
will be selected: the proximal and distal acupoints
connected to the areas of pain.
For distal acupoints,the individualized acupuncture
method is based on the five elements principle in Sa-am
acupuncture as well as the 12 meridian theory.
According to this theory, the four causes of imbalances
in meridian energies are deficiency, excess, cold and
heat. Since there are 12 meridians with four possible
imbalances, there are a total of 48 pre-established acu-
puncture prescriptions, each with five Shu transport
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12 meridians, however, only six pass through the knee.
After asking the patient which part of the knee exhibits
the greatest amount of pain, the certified oriental medi-
cine doctor will determine which of the six meridians
passing through the knee is closest to the source of pain
and treat that meridian with the four Sa-am acupoints
listed in Table 1. After inserting the needles, the practi-
tioner will rotate the needles either clockwise or coun-
terclockwise for tonification and sedation [26].
By allowing the practitioners to choose the meridian
channel based on each patient's symptoms, the proposed
approach will provide patients with individualized ther-
apy within a general, replicable framework. Before each
treatment, a certified oriental medicine doctor will deter-
mine whether the patient’s clinical condition has
changed; if so, the selection of acupuncture points will
be reconsidered.
For proximal acupoints,in addition to using Sa-am
acupuncture on the distal acupoints, proximal acupoints
will be selected for each individualized treatment, since
this is common practice for oriental medicine doctors in
Korea. Based on the knee area in which each patient
experiences pain, a certified oriental medicine doctor
will choose two Ashi points connected to the area of
pain, as well as three acupoints from the five popularly
used acupoints:SP9(Yinlingquan), ST35(Dubi), EX-LE5
(Xiyan), BL39(Weiyang) and EX-LE2(Heding). Since
electrical stimulation can only be done in pairs, four of
the five proximal acupoints will be stimulated electrically
with a mixed wave frequency between 2Hz and 100Hz.
Standard acupuncture
The standard acupuncture treatment method for knee
OA has already been described by Berman et al. [27].
The methods and materials used will be the same as
those in the individualized acupuncture group, except
for the selection of acupoints and electrical stimulation.
Standard treatment will require the use in all patients of
nine acupoints: SP9,GB34, ST36, ST35, EX-LE5 (Xiyan),
BL60, GB39, SP6 and KI3.Electrical stimulation will also
be applied to Xiyan knee points at a low frequencyTable 1 Acupoints for individualized treatment
Distal acupoints(four)
Spleen deficiency(HT8, SP2(+), LR1, SP1(−))
Kidney deficiency (LU8, KI7(+), SP3, KI3(−))
Liver deficiency (KI10, LR8(+), LU8,LR4(−))
Gallbladder deficiency (BL66, GB43(+), LI1, GB44(−))
Bladder deficiency (LI1, BL67(+), ST36, BL40(−))
Stomach deficiency (SI5, ST41(+), GB41, ST43(−))
One of the six possible meridians were selected for treatment
+/−, signifies that these points have been rotated bidirectionally to stimulate tonific(8 Hz), with square biphasic pulses for 20 minutes, as
previously described [27].
Sham acupuncture
Sham acupuncture treatment will be performed using a
non-penetrating acupuncture device, Parksham acupunc-
ture (DongBang Acupuncture Inc), consisting of a tooth-
pick in a needle guide-tube, which is used to mimic needle
insertion and withdrawal. Acupuncture-naïve patients find
this method to be indistinguishable from true acupuncture
[24], even though the needles do not penetrate the skin.
Sham acupuncture will be applied to the same nine acu-
puncture points as in the standard acupuncture group.
This Parksham acupuncture device has been used in sev-
eral previous clinical research studies [28-30].
To simulate electrical stimulation, a mock-electrical
stimulator (STN-111, StraTek Co)with the same appear-
ance and sound as the conventional electroacupuncture de-
vice will be used, but without actual electrical stimulation.
No acupuncture treatment group
Patients in the control group will receive no acupunc-
ture treatments, but will be assessed at each visit.
Quality assurance
To ensure that treatments are of a high standard and de-
livered in accordance with the trial protocol, the qualifi-
cations and training certifications of each oriental
medicine doctor will be thoroughly checked prior to the
start of the trial. All treatments will be administered by
practitioners with extensive clinical experience perfor-
ming acupuncture for knee pain and the following quali-
fications:1. graduation from a 6-year, full-time course in
oriental medicine, taught as a college program;2. certifi-
cation by the Korean Ministry of Health and Welfare as
an oriental medicine doctor;3. more than 1 year of
postgraduate clinical training in an oriental medicine
hospital; and 4. completion of the first-year residency
program in the Department of Acupuncture and
Moxibustion at Dongguk and Semyung University.
Prior to inclusion in this trial, each clinician will
attend a 2-day training workshop on the methods ofProximal acupoints (five)
Three of five acupoints(SP9, ST35, EX-LE5, BL39, EX-LE2)
plus two Ashi points
ation (+) and sedation (−).
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sham needle-guiding tubes,provided written protocols
and standardized recording documents. Since the inter-
actions between oriental medicine doctors and partici-
pants can strongly influence the outcome of treatment,
these interactions will be strictly limited, except when
checking the patient’s health and reporting adverse
events during the course of the trial.
In addition, to improve the quality of the study, out-
come assessors will be blinded to group allocation and
will not be involved in providing the interventions. To
further ensure that the patients are blinded to group
allocation, a cloth barrier will be placed onto each
participant's neck to prevent the patient from seeing the
acupuncture treatment taking place.
Analysis of data
The primary efficacy endpoint of the study will be the
change in Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) [31] score from before
to after the 6-week, 12-visit trial.
The WOMAC is a widely used, reliable, valid and re-
sponsive measure of treatment outcomes in patients
with OA of the hip or knee [31]. The WOMAC index
consists of 24 questions (5 related to the amount of pain,
2 to stiffness and 17 to physical function), and takes less
than 5 minutes to complete [32]. The Likert version of
the WOMAC rates each question on an ordinal scale of
0 to 4, with lower scores indicating lower levels of symp-
toms or physical disability [33].
Secondary efficacy endpoints will include: 1. the suc-
cess rate of treatment; 2. change in scores on the
WOMAC pain subscales; 3. 100 mm pain VAS on
walking; 4. results of a 6-minute walk test; and 5.investi-
gator global assessment (IGA)/patient global assessment
(PGA). Treatment success will be defined as ≥36% im-
provement in WOMAC score, and treatment failure by
a change <36% in WOMAC score or a missing valueTable 2 Example of outcome measurements
Measures Treatment visit





WOMAC pain(subscale) x x x x x
100 mm pain VAS on walking x x x x x
6-minute walk test x
IGA/PGA x x x x x
aThe primary outcome is the change of WOMAC score after the 12-visit, 6-week tria
as <36 % improvement or missing values.IGA, investigator global assessment; PGA,
Ontario and McMaster Universities Osteoarthritis Index.[34].The 100 mm pain VAS on walking is used to evalu-
ate the severity of pain. The patient will be asked to walk
15 m in a straight line and to determine his/her level of
pain from 0 mm (absence of pain) to 100 mm (worst
pain imaginable).The 6-minute walk test, which mea-
sures the distance a person can walk in 6 minutes, has
been found to reliably measure functional exercise cap-
acity and has been frequently used in OA-related trials
[35,36]. For IGA and PGA, the oriental medicine doctor
and the patient, respectively, will evaluate general im-
provements in OA pain-related symptoms, using a five-
grade scale: excellent, good, fair, poor and aggravated.
The 100 mm VAS on walking, WOMAC pain scale and
IGA/PGA will be assessed at baseline, at each treatment
session, and 12 weeks after the start of treatment. The
WOMAC and 6-minute walk tests will be assessed at
baseline, and after 3, 6 and 12 weeks from the start of
the trial.
In addition, the patients will be asked to record their
symptoms according to a VAS each morning and even-
ing during the duration of the trial. They will also be
asked to record the medications they take, such as anal-
gesics and NSAIDs for knee pain, at the beginning of
the trial, at each treatment session, at the end of treat-
ment (week 6), and at 12 weeks after the start of the
treatment (Table 2).
Any reported adverse events will be recorded throughout
the study, and vital signs will be monitored at each visit.
Sample size
The primary efficacy parameter is change in WOMAC
score from baseline to the end of treatment after 6 weeks.
The standard deviation (SD) of the WOMAC score is
3.35 [27]. In calculating the appropriate sample size for
this study, we sought to obtain a more conservative SD,
with a true mean difference of 2.34.
With μ1 and μ2 representing the mean WOMAC
scores for the test and control groups, respectively, the5 6 7 8 9 10 11 12 Follow-up
x x x
x x x
x x x x x x x x x
x x x x x x x x x
x x x
x x x x x x x x x
l.bSuccess will be defined as ≥36 % improvement in WOMAC score, and failure
patient global assessment; VAS, visual analogue scale; WOMAC, Western
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H0 : μ1−μ2 ¼ 0
will be tested versus the alternative hypothesis
H1 : μ1−μ2≠0
Using these hypotheses, we calculated the sample size
needed to achieve 80% power using the equation:





To show that the individualized treatment group is
not equal to the control groups, patients will be ran-
domized 2:2:1:1 to the individualized treatment group,
standard treatment group, sham group and untreated
group, respectively. Using these assumptions and specifi-
cations, a sample size of 198 individuals (66:66:33:33)
will provide a power of 80% at a significance level of
0.05. To allow for a 20% dropout rate, a slightly higher
number, 250 patients, will be randomized in the trial.
Statistical analysis plan
All statistical analyses will be performed using SAS ver-
sion 9.1 or a later version. All statistical tests will be
two-sided and the level of significance will be set at 0.05.
The last observation carried forward (LOCF) method
will be used to input data with dropouts. Continuous
variables will be expressed as mean ± SD, and categorical
variables as number and percentage.
The primary endpoint will be compared in the four
groups by analysis of covariance (ANCOVA),with treat-
ment means adjusted to baseline WOMAC scores as a
covariate. Confidence intervals will be derived from
ANCOVA. Repeated measures analysis of variance
(ANOVA) will also be used to analyze primary and sec-
ondary efficacy variables. Categorical data will be analyzed
using Pearson’s chi-square test or Fisher’s exact test.
Discussion
The individualized acupuncture treatment method pro-
posed in this study, consisting of meridian-based syn-
drome differentiation and Sa-am acupuncture, is not
only the most commonly method used by certified
oriental medicine doctors in Korea to treat patients with
OA [21,25], but can be generalized for widespread use in
the future. In this trial, we will evaluate the efficacy of
this individualized treatment method by comparing it
with standard, sham and non-treatment groups.
The acupuncture methods employed in this study are
the closest to actual clinical practice and can be used in
future studies. Moreover, the techniques of meridian
based and Sa-am acupuncture that we will use in this
study are based on the consensus of many certifiedoriental medicine doctors in Korea. In addition, we will
strive to conduct a high quality, single-blinded clinical
trial by ensuring that the assessors and participants are
not informed of the type of treatment, by using a variety
of controls including Park sham acupuncture, and pro-
viding trial-specific training of the exact methods used
to well-qualified and certified oriental medicine doctors.
In conclusion, this research involves three different
controls, and it will help elucidate the efficacy of individ-
ualized acupuncture versus standard, sham and no acu-
puncture groups.
Trial status
Participant enrollment is still being undertaken. Enroll-
ment and trial completion is expected to be finished by
the end of 2013.
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